Wall Street Loves EV3-FoxHollow Merger

The market capitalization of the two up-and-coming firms would combine for a value of about $1.7 billion, and its annual sales would total about $600 million.EV3 and FoxHollow are both major innovators in endovascular technology, and both firms have been touted highly by Wall Street analysts for years. The companyâEUR(TM)s combined product portfolio will include atherectomy and thrombectomy devices, PTA balloons, stents, embolic protection devices, infusion catheters and wires, embolic coils and liquid embolics.